Interest in B cells has recently increased, with immunotherapies using engineered B cells or tumour-infiltrating lymphocytes (TILs). However, current methods for B cell expansion are inefficient and time-consuming, and can lead to insufficient B cell numbers and persistent T cell exhaustion. AdipoGen’s B-Xpander protein is designed to improve current protocols for B cell stimulation by mimicking the natural interaction between CD40L and CD40 molecules on B cells.
The product is a potent enhanced multimeric human CD40L cytokine, suitable for B cell activation, B cell expansion (proliferation) and cell therapy applications. In-house production using a proprietary protocol and a characterised and certified CHO cell line allows the supply of active multimeric human CD40L proteins in GMP-like format. The product is available in standard grade, animal-free (AF) grade and certified serum grade (CSG).
Other features include: production in characterised and certified CHO cell line; high bioactivity tested by ELISA/cell-based assays; verified purity and homogeneity by SEC; low endotoxin levels; batch-to-batch consistency; animal-component free production; and no cross-linking reagents necessary.
Phone: 02 9698 2022
Revvity Dharmacon ON-TARGETplus siRNA for precision gene knockdown
Dharmacon ON-TARGETplus siRNAs by Revvity combine a patented dual-strand modification pattern...
AdipoGen Life Sciences InVivoKines recombinant fusion proteins
InVivoKines are recombinant fusion proteins for immunotherapeutic, preclinical and translational...
PhenoSys qOMR system for objective vision assessment in mice
PhenoSys introduces the qOMR (quantitative Optomotor Response) system, a fully automated platform...

